Caris Life Sciences, Inc. (CAI) has 11 SEC Form 4 insider filings on record in the last 90 days. That includes 1 insider purchase totalling $990K. Most recent filing: Sept. 17, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 17, 2026 | Brille Brian J See Remarks | $11,156,080 | 1,200,000 | 0% | No | |
|
|
||||||
| Sept. 4, 2026 filed Sept. 3, 2026 | Spetzler David Baxley President | — | +652,788 | — | No | |
|
|
||||||
| Aug. 14, 2026 | CASTLEMAN PETER M Director | $0 | 13,192 | +82% | No | |
|
|
||||||
| Aug. 14, 2026 | Minor Lloyd Director | $0 | 13,192 | +71% | No | |
|
|
||||||
| Aug. 14, 2026 | PHILLIPS T DANNY Director | $0 | 13,192 | +11% | No | |
|
|
||||||
Showing the 5 most recent of 11 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free